Community Trust ScoreVerified
In a notable move toward digital asset integration, Wellgistics Health (NASDAQ: WGRX) has filed an S-1 form with the U.S. Securities and Exchange Commission (SEC), revealing detailed plans to use XRP and the XRP Ledger (XRPL) for low-cost, real-time payment solutions. Ripple-affiliated lawyer Bill Morgan highlighted the development on social media, pointing out its broader implications for institutional crypto adoption.
XRP and XRPL Enter Healthcare
The Florida-based healthcare firm, which operates a large distribution network serving independent pharmacies and manufacturers, has begun leveraging XRPL to process real-time transactions. The initiative is not just about holding XRP as a reserve asset. According to its SEC filing, Wellgistics aims to actively use XRP for payments between its internal network and external partners.
The company intends to use its existing XRP holdings as collateral for financing, raise additional capital to purchase more tokens, and even generate income through the asset—an approach Bill Morgan described as “XRP working hard for WH.”
This hands-on use of XRPL reflects a shift in how public companies are approaching crypto integration, especially in regulated sectors like healthcare. The XRPL’s ability to settle transactions instantly and at low cost appears to align with Wellgistics’ goal of streamlining its supply chain.
Lawyer Bill Morgan Calls It “Tangible Utility”
Morgan, who frequently comments on Ripple-related developments, framed the move as a strong business case for XRPL. He noted that the Wellgistics strategy touches on several key aspects: using XRP as a reserve asset, collateral, payment rail, and income-generating tool—all within one framework.
While critics continue to argue that XRP lacks real-world utility, Morgan said this example provides a counterpoint. It marks a practical use case that extends beyond speculation.
Citing Risks, Wellgistics Moves Forward Anyway
The company acknowledged in its filing that regulatory uncertainty surrounding XRP poses risks, especially given the ongoing lawsuit between Ripple and the SEC. Nonetheless, it has committed significant resources toward building its infrastructure on XRPL.
In fact, Wellgistics secured a $50 million equity line from LDA Capital, a private investment group with experience in crypto-backed financing. The flexible arrangement allows the firm to draw capital as needed by issuing shares. That funding is expected to accelerate XRP integration across a national network of more than 6,000 pharmacies and 150 manufacturers.
Broader Trend: Institutions Using XRPL
Wellgistics is not alone in its exploration of XRP-based solutions. Other publicly traded firms like Nature’s Miracle and Mercado Bitcoin have also tapped XRPL for tokenization efforts. Ripple’s recent partnership with Mercado Bitcoin aims to tokenize $200 million worth of real-world assets on the ledger—another sign of growing institutional interest.
CEO: “We’re Betting on Infrastructure”
In a May statement, Wellgistics Health CEO Brian Norton emphasized the strategic importance of adopting modern financial rails:
“I believe that the future winners in healthcare will not be the companies with the biggest buildings—they will be those with the fastest rails, cleanest data, and most efficient platforms. We are betting on infrastructure—not inertia.”
That statement underscores the company’s long-term vision for using blockchain to build a more responsive, data-driven healthcare supply system. While regulatory risks remain, Wellgistics appears confident that XRPL’s efficiency and scalability can offer tangible value across its operations.
